Comparative Pharmacology
Head-to-head clinical analysis: MEPERIDINE HYDROCHLORIDE PRESERVATIVE FREE versus WESTADONE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: MEPERIDINE HYDROCHLORIDE PRESERVATIVE FREE versus WESTADONE.
MEPERIDINE HYDROCHLORIDE PRESERVATIVE FREE vs WESTADONE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Meperidine is a synthetic opioid agonist that exerts its analgesic effects by binding to mu-opioid receptors in the central nervous system, thereby mimicking the actions of endogenous opioids. It also has some kappa-opioid receptor activity and weak serotonergic effects.
Mu-opioid receptor agonist; also acts as an NMDA receptor antagonist and inhibits serotonin and norepinephrine reuptake.
50-100 mg IM/SC every 3-4 hours as needed; 25-50 mg IV slowly every 3-4 hours as needed.
Oral: 2.5-10 mg every 4-6 hours as needed for pain; maximum 40 mg per day.
None Documented
None Documented
Terminal elimination half-life: 2.5–4 hours (mean 3.2 h). In cirrhosis, half-life prolonged to 7–11 hours; in elderly, half-life extends up to 8 hours. Normeperidine (active metabolite) half-life: 15–30 hours (accumulates with renal impairment).
Terminal elimination half-life: 15-60 hours (mean ~24 hours). Clinical context: Prolonged half-life supports once-daily dosing in opioid maintenance; accumulation occurs with repeated dosing due to long half-life.
Primarily renal (90% as metabolites, ~5-30% unchanged); biliary/fecal excretion accounts for <10%. Urinary excretion is pH-dependent; acidic urine increases elimination.
Primarily renal (40-50% as unchanged methadone and its metabolites, 15-20% as metadone-N-oxide), biliary/fecal (5-10%).
Category D/X
Category C
Opioid Agonist
Opioid Agonist